Back to Directory

Antigenika

Founded 2024
Oral small-molecule treatment for snakebite envenoming

Antigenika is a biopharmaceutical company developing an oral treatment for snakebite envenoming. Its approach combines repurposed small-molecule drugs in a tablet intended for use soon after a bite, including where the snake species is unknown. The programme grew out of venom pharmacology research at the University of Reading. The company reports completing preclinical testing against multiple venoms and is preparing its first safety study in healthy volunteers.